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Abstract Angiogenesis, the formation of new blood vessels sprouting from existing
ones, occurs in several situations like wound healing, tissue remodeling, and near
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growing tumors. Under hypoxic conditions, tumor cells secrete growth factors, in-
cluding VEGF. VEGF activates endothelial cells (ECs) in nearby vessels, leading to
the migration of ECs out of the vessel and the formation of growing sprouts. A key
process in angiogenesis is cellular self-organization, and previous modeling stud-
ies have identified mechanisms for producing networks and sprouts. Most theoretical
studies of cellular self-organization during angiogenesis have ignored the interactions
of ECs with the extra-cellular matrix (ECM), the jelly or hard materials that cells live
in. Apart from providing structural support to cells, the ECM may play a key role in
the coordination of cellular motility during angiogenesis. For example, by modifying
the ECM, ECs can affect the motility of other ECs, long after they have left. Here,
we present an explorative study of the cellular self-organization resulting from such
ECM-coordinated cell migration. We show that a set of biologically-motivated, cell
behavioral rules, including chemotaxis, haptotaxis, haptokinesis, and ECM-guided
proliferation suffice for forming sprouts and branching vascular trees.
Keywords Angiogenesis · Extracellular matrix · Cellular Potts model · Branching
growth · MMPs
1 Introduction
The outgrowth of new blood vessels from preexisting vessels, called angiogenesis, is
a crucial step in many physiological and pathological mechanisms, including wound
healing and tumor growth. Once cells in a tissue, e.g., a growing tumor, are short
in oxygen or nutrients, they secrete a range of angiogenic growth factors (De Smet
et al. 2009), including vascular-endothelial growth factor (VEGF). VEGF activates
endothelial cells (ECs), the cells forming the inner lining of blood vessels, resulting
in increased cell survival, migration, and proliferation. The activated ECs differen-
tiate into stalk and phalanx cells—forming the body of the sprout—and a tip cell
phenotype that migrates chemotactically toward the source of VEGF (De Smet et al.
2009). Initially, VEGF stimulates filopodial extensions of specialized ECs, called tip
cells (Gerhardt et al. 2003). The sprout grows out as the ECs further down in the
sprout proliferate (Gerhardt et al. 2003). Angiogenesis is a topic of intensive ex-
perimental investigation so its phenomenology and the molecular signals contribut-
ing to it have been well characterized (Carmeliet 2005; Carmeliet and Jain 2000;
Folkman 2007). Yet it is poorly understood how the biological components fit to-
gether dynamically to drive the outgrowth of blood vessels.
A key process in angiogenesis is cellular self-organization. ECs cultured in vitro
autonomously organize into vascular networks (Folkman and Hauenschild 1980);
and ECs move along growing sprouts (Jakobsson et al. 2010). Thus, an impor-
tant question becomes what (genetically regulated) cell behaviors and cellular re-
sponses are responsible for the self-organization of endothelial cells into blood ves-
sel sprouts. To answer this question, cell-based computational models take as in-
put a set of measurable and quantifiable behaviors and the responses of individ-
ual cells to chemical and mechanical cues from the microenvironment. The out-
put of the model is a prediction of the resulting collective behavior of the cells
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that was not explicitly prescribed, e.g., the formation of a sprout, sprout branch-
ing, and sprout anastomosis (Merks and Glazier 2005; Merks and Koolwijk 2009;
Anderson et al. 2007). In this way, previous cell-based models have predicted poten-
tial mechanisms for the formation of vascular networks (Merks et al. 2004, 2006;
Szabo et al. 2007, 2008; Guidolin et al. 2009; Scianna et al. 2011; Köhn-Luque
et al. 2011) and angiogenic sprouting (Bauer et al. 2007, 2009; Merks et al. 2008;
Szabo et al. 2008). Thus, a cell-based model allows us to mechanistically dissect
the workings of a biological mechanism in a predictive fashion, because each of the
model assumptions corresponds with a biological component accessible to experi-
mental manipulation.
This cell-based approach to computational modeling of angiogenesis contrasts
with a number of previous, descriptive models of angiogenesis (e.g., Anderson and
Chaplain 1998; Milde et al. 2008; Sun et al. 2005; Owen et al. 2009; Perfahl et al.
2011; Watson et al. 2012). Although such models successfully simulate many phe-
nomena associated with angiogenesis, a problem is that model input and model out-
put are not always strictly separated: In addition to rules for tip cell motility, these
models include explicit, descriptive rules for tip branching, anastomosis, and spe-
cific assumptions to prescribe the length of the branches and sometimes branching
angles. Descriptive models are very helpful because they can integrate our current
experimental knowledge of a developmental mechanism, but—in contrast to a cell-
based model—they cannot help dissect and integrate the underlying molecular and
cellular mechanisms responsible for the mechanisms they prescribe explicitly. The
agent-based models of Bentley and coworkers do take a predictive approach, like
cell-based models, focusing on the molecular and cellular signaling mechanisms re-
sponsible for tip and stalk cell selection (Bentley et al. 2008, 2009). This model has
suggested a novel, filopodia-mediated tip-cell selection mechanism, the molecular
level of the model is experimentally plausible, and it has guided experimental studies
(Jakobsson et al. 2010; Guarani et al. 2011). However, because in this model cells
cannot move relative to one another, the model is not suited for our purpose: studying
cellular self-organization in which cell motility is a key process.
Although cell-based simulation studies show how collective cell behavior can pro-
duce vascular networks and angiogenic sprouts, many lack a detailed description of
the extracellular matrix (ECM), the jelly or hard materials that cells secrete. The
ECM provides mechanical support to endothelial cells, and mediates signaling via
secreted molecules (Hynes 2009) and mechanical strains (Reinhart-King et al. 2008)
between cells (Davis and Senger 2005). Cells can pick up molecular signals in the
ECM long after another cell left it there. Mechanical signals, in the form of tissue
strains and stresses to which cells respond (Mammoto et al. 2009), can act over long
distances and integrate mechanical information over the whole tissue (Nelson et al.
2005). Thus, apart from providing structural support, the ECM is key to cellular co-
ordination, because (a) it stores cellular signals over a long time, or it is such a cellu-
lar signal itself, and (b) it integrates biomechanical information over long distances.
Thus, the ECM is a key component of the microenvironment that endothelial cells
live in and cannot be ignored in computational models.
The cell-based models by Bauer and coworkers (Bauer et al. 2007, 2009) focus
on the role of the ECM as an obstacle and directional guidance cue for EC migra-
tion. Representing ECM fibers as static obstacles they demonstrate how ECM fibers
1380 J.T. Daub, R.M.H. Merks
distributed in uniform or directionally-biased random orientations can direct the mi-
gration of a growing angiogenic sprout. Also, their model shows how local variations
in ECM density can induce sprout splitting (Bauer et al. 2007). In their model of in
vitro vasculogenesis, Köhn-Luque and coworkers (Köhn-Luque et al. 2011) focus on
the role of the ECM as a storage of growth factors, showing how endothelial cells
can induce local gradients of chemoattractants by secreting proteolytic enzymes that
locally release ECM-bound VEGF molecules. Apart from these models based on the
Cellular Potts method (CPM), the partial-differential equation (PDE) models of vas-
culogenesis by Manoussaki and coworkers (Manoussaki et al. 1996, 2003) and those
of Tracqui and coworkers (Namy et al. 2004) study the ECM as a medium for biome-
chanical signaling. Thus, previous cell-based models have studied the function of the
ECM as a barrier for cell migration (Bauer et al. 2007, 2009) or as an local inacti-
vating storage for chemotactic signals that proteolytic enzymes release (Köhn-Luque
et al. 2011).
Because cells can digest the ECM and secrete new ECM materials, the ECM can
also function as a “written” cellular signal, that “records” previous positions of the
ECs and facilitates the motility of subsequent ECs. Several variants of such facilitated
random walk mechanisms were proposed for angiogenesis. Yin and coworkers (Yin
et al. 2008) showed that cells deposit collagen in microfluidic devices. This produces
tracks that other ECs can follow by altering their velocity in response to the collagen
trail collagen. They also found that stimulation by VEGF inhibits the track-following
behavior of the ECs. An agent-based model demonstrated that this VEGF-inhibited
track-following behavior produces vascular trees with a typical “brush-border”-effect
(enhanced branching) near a source of VEGF, e.g., a tumor. Levine (2001a, 2001b)
and Plank and Sleeman (2003) proposed that tip cells locally secrete proteolytic en-
zymes that digest the ECM and allow the tip cell to pass through. A similar approach
was taken by Anderson and Chaplain (1998). They proposed a continuous model
for tumor-induced angiogenesis, and derived from that a discrete, stochastic model
simulating the motility of ECs. Their model simulates migration of endothelial cells
from a parent vessel toward a tumor, which chemotact along a gradient of angiogenic
growth factors that the tumor produces. The ECs interact with the surrounding extra-
cellular matrix by breaking down and secreting fibronectin, an extracellular matrix
component. The ECs’ migration is biased toward higher fibronectin concentrations,
a process called haptotaxis; as a result, the ECs spread into “fresh” fibronectin by
breaking it down locally and migrating to a nearby location with higher fibronectin
concentration. We have recently introduced a computational model of sprout forma-
tion in an in vitro assay of angiogenic sprouting from endothelial monolayers in fibrin
matrices (Boas et al. 2013). In that model, fibrin acts as an obstacle for cell migration.
Tip cells secrete uPA that degrades fibrin so cells can migrate into the fibrin. In the
present paper, we further explore the effect of proteolysis-based cell-ECM interac-
tions in a cell-based model, describing the behavior of both the endothelial cells at
the tip and the trailing endothelial cells. In contrast to the model by Boas et al., we
here represent the ECM with a continuous field, and model the effect of the ECM on
cell motility in more detail.
The ECM can affect cell motility in at least two ways. First, ECs can follow local
gradients, crawling to higher concentrations of the ECM, a process called haptotaxis
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(Lamalice et al. 2007). Second, ECs can increase or reduce their motility in response
to the absolute concentrations of ECM, a mechanism called haptokinesis. Typically,
cell speed, spreading, and membrane activity is maximal at intermediate levels of
ECM densities, both on 2D substrates (Chon et al. 1998; Cox et al. 2001; DiMilla
et al. 1993; Gaudet et al. 2003; Palecek et al. 1997; Wu et al. 1994) and in 3D matrices
(Zaman et al. 2006).
To generate ECM gradients, ECs locally degrade or deposit matrix proteins
(e.g., fibronectin and collagen). After VEGF-stimulation, ECs produce diffusing
and membrane-bound proteolytic enzymes, among which are the matrix metallopro-
teinases (MMPs) that can proteolytically degrade almost every ECM protein. The
membrane bound MT-MMP is a key player in this process, breaking down ECM
components close to the tip of the sprout, and inducing the release of other MMPs
like MMP2 (Pepper 2001; van Hinsbergh and Koolwijk 2008).
Could such signaling via a nondiffusing ECM coordinate collective cell behavior
during angiogenesis? To address this question, we constructed a hybrid CPM-PDE
model, based on the following, biologically plausible assumptions: (1) Tumors se-
crete VEGF resulting in a VEGF gradient (Folkman 2007); (2) VEGF induces secre-
tion of diffusive MMPs by endothelial cells. (3) MMPs degrade ECM components
near the cell surface. (4) ECs move along VEGF gradients (Gerhardt 2008; Gerhardt
et al. 2003) and they (5) migrate toward higher ECM densities (Lamalice et al. 2007;
Senger et al. 2002). (6) Cell speed and spreading are optimal at intermediate ECM
densities and (7) cells proliferate if a large part of their surface is in contact with
the ECM (Ausprunk and Folkman 1977; Coomber and Gotlieb 1990). In the present
model, we ignore the differentiation of ECs into tip and stalk cells (Gerhardt et al.
2003; De Smet et al. 2009; Phng and Gerhardt 2009). With these assumptions, our
model is probably most similar to the model of Anderson and Chaplain (1998), who
considered assumptions (1)–(5). New in our model are assumptions (6) and (7). Also,
our model does not need any additional rules for branching or anastomosis. All the
angiogenesis-like phenomena reported here are exclusively due to assumptions (1)–
(7). We show that these suffice for robustly branched vascular trees, in the absence of
explicit model rules for vascular branching. In the remainder of this paper, we first
describe our model and illustrate the contribution of each of the assumptions to pro-
ducing a vascular tree. Next, we provide a thorough parameter analysis. We end by
discussing the biological relevance of our model observations and discussing future
directions.
2 Model Setup
We model endothelial cells using a Cellular Potts model (CPM) (Glazier and Graner
1993) (aka Glazier–Graner–Hogeweg model), a lattice-based cell-based modeling
technique that represents cells as a connected domain of square lattice sites. It sim-
ulates stochastic cell motility by iteratively expanding and contracting the domains,
depending on a set of cell behavior rules; see Sect. 2.1 for a detailed description.
We use a partial-differential equation (PDE) description for fields of extracellular
matrix materials, proteolytic enzymes, and diffusing growth factors. The model do-
main is similar to that used by previous authors (Anderson and Chaplain 1998;
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Fig. 1 Setup of model domain. A Initial cellular Potts model configuration (endothelial cells) and ex-
tracellular matrix field. To mimic an early stage vessel sprout, 125 cellular Potts cells, each consisting
of approximately 50 lattice sites are positioned behind a digested vessel wall, on top of a uniform ECM
concentration. B Steady state VEGF field; C Initial ECM field
Yin et al. 2008): in a rectangular dish of 250 × 300 lattice units (corresponding to
approximately 500 µm × 700 µm) 125 endothelial cells are placed behind a vessel
wall situated at the bottom of the dish. The cells can migrate toward the top of the
dish through a gap of 25 lattice units in the wall in the direction of a tumor, which
we assume to be located beyond the top of the dish (Fig. 1A). We define only one
type of cell, so we do not distinguish tip cells and stalk cells. A set of three PDEs
describes the concentrations of VEGF, MMPs and ECM components. We solve the
PDE for VEGF analytically, and solve the two coupled PDEs for MMPs and ECM
concentration numerically.
2.1 Cellular Potts Model
The CPM represents biological cells as patches of lattice sites. Each cell has a unique
index σ ∈ N, which is assigned to every lattice site that is occupied by that cell.
The type of a cell σ is denoted with τ(σ ) ∈ N. The extra-cellular matrix (ECM)
consists of all lattice sites not occupied by cells and is labeled with index σ = 0
and type τ = 0. The interfaces between adjacent lattice sites x and x′ with unequal
index σx = σx′ represent membrane bonds, with an associated, cell-type dependent
adhesion energy given by J (τ(σx), τ (σx′)) (Fig. 2A). An area constraint penalizes
cell shapes deviating too much from their preferred area; to drive cell elongation we
use a length constraint, which penalizes cell shapes shorter or longer than a target
length (Merks et al. 2006). The ECM has no area or length constraint.
The “effective energy” is given with the CPM Hamiltonian:
H =
∑
(x,x′)
J
(
τ(σx), τ (σx′)
)(
1 − δ(σx, σx′)
) + λA
∑
σ
(
A(σ) − AT (σ)
)2
+ λL
∑
σ
(
L(σ) − LT (σ )
)2
(1)
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Fig. 2 Cellular Potts model and interaction with extracellular matrix. A Lattice with two adjacent en-
dothelial cells (grey), surrounded by an extracellular matrix (white). Double arrows represent cell–cell
and cell-ECM adhesive bonds. For simplicity, diagonal bonds are not shown. B Haptokinesis energy term
(Eq. (8)) for η = 1, μ = 0.5, and ρ = 0.2
where (x, x′) is a pair of adjacent lattice sites, δ is the Kronecker delta, A(σ) is the
current area of cell σ , AT (σ) is its target area, and λA is an area elasticity parameter;
similarly, L(σ) represents the current length of cell , LT (σ ) is its target length and
λL is the strength of the length constraint. The optimal way to minimize both the
length constraint and adhesion energies together is to split the cell into two rounded
patches; we therefore require an additional connectivity constraint. The cell length
estimation method and connectivity constraint algorithm are described in detail else-
where (Merks et al. 2006).
To mimic membrane extensions and retractions, we repeatedly attempt to replace
the index σx of a random lattice site x by the index σ ′x of one of its random adjacent
sites x′. We calculate H , the change in total effective energy H that would occur if
we performed the copy, and accept the attempt with Boltzmann probability:
P(H) =
{
e−H/M if H ≥ 0,
1 if H < 0,
(2)
where M defines the intrinsic random motility of the cell membranes. This allows
energetically unfavorable cell movements. Note that we define cell motility here as
the active movement of the cell’s perimeter driven by extension and retraction of
pseudopods, which may or may not lead to cell migration.
We will set the target area AT (σ) = 50 lattice sites and the target length LT (σ ) =
15 lattice sites. We set the adhesion energy at cell–cell borders JCC = 40 and at
cell–matrix borders, JCM = 25, in order to make attachments between cells slightly
favorable over cell–matrix bonds; hence the surface tension becomes γCM = JCM −
1
2JCC = 5 > 0, so cells adhere to one another (Glazier and Graner 1993). The intrinsic
motility parameter is set to M = 100.
When performing a copy attempt we select the source site x′ from the 20, first-
to fourth-order nearest neighbors of x, to improve the isotropy (Holm et al. 1991;
Marée et al. 2007). During a Monte Carlo Step (MCS), we carry out N copy attempts
where N is the total number of lattice sites in our dish. We define a high cell-border
energy to prevent cells from adhering to the boundaries of the lattice.
The remainder of Sect. 2 describes the implementation of the endothelial cell be-
haviors that our model describes. Figure 3 summarizes the effect of each of these
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Fig. 3 Incremental overview of effect of model components. For parameters, see Table 2. A Only adhe-
sion energy and area and length constraints; B after adding chemotaxis along a vertical source of VEGF
(Eqs. (3)–(5)); C after adding an initial layer of ECM and a haptokinesis rule (Eq. (8)); note that this con-
centration of ECM prevents cells from moving; D after adding proteolysis (Eqs. (6)–(7)) the cells coast
along trails of intermediate ECM concentration; E the proliferation rule (Eq. (9)) allows cells to form
connected branches; F haptotaxis (Eq. (12)) enhances branching. See also Supplementary Movie 1
assumptions on the collective behavior of the simulated ECs. For example, with only
the adhesion and area and length constraints described so far, cells migrate out of the
parent vessel forming a clump of cells (Fig. 3A).
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Table 1 Unitless reference values of model parameters
Parameter Value Description
χ 5000 chemotaxis strength
Γ 300 haptotaxis strength
s 7.0 saturation haptotaxis
η 200 haptokinesis strength
EM 3 × 10−3 decay rate ECM
αMV 8 × 10−5 secretion rate MMPs
M 1 × 10−3 decay rate MMPs
DM 1 × 10−14 diffusion coefficient MMPs
DV 6 × 10−11 diffusion coefficient VEGF
V 1 × 10−3 decay rate VEGF
ρmin 0.73 threshold ratio for proliferation
λA 25 parameter area constraint
λL 25 parameter length constraint
cE,init 0.9 initial ECM density outside parent vessel
cV (0) 0.87 VEGF concentration near tumor
X 250 width of dish (lattice sites)
Y 350 length of dish (lattice sites)
Ygap 30 distance vessel wall from bottom of dish
Xgap 25 width of gap in vessel wall (lattice sites)
MCStot 40000 number of total MCS
For simplicity and current lack of quantitative data, we use the set of unitless,
reference parameter values listed in Table 1, and study their relative importance in
Sect. 3. As Supplementary Text 1 demonstrates, the results hold if empirical values
are used where they are known, choosing appropriate values for the remaining free
parameters. However, it is unclear to what extent these free parameters can correct
for imprecise values of the “known” parameter values. We therefore prefer to work
with dimensionless parameter sets here, thus avoiding the impression that our model
results were quantitatively valid at present. To validate our model, we instead per-
form parameter sensitivity analyses (Sect. 3), and compare its results with published,
qualitative experiments.
2.2 Chemotaxis along VEGF Gradient
We define a tumor nearby the vessel, at the top of the simulation domain. We assume
the tumor produces VEGF uniformly and throughout, allowing us to approximate
it as a planar source at the top. The VEGF degrades at a rate proportional to the
concentration, cV ,
∂cV
∂t
= −V cV + D∇2cV (3)
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with D, the diffusion coefficient and V , the degradation rate of VEGF. In the simu-
lations presented in this paper, we assume for simplicity that the gradient is at steady
state, ∂cV
∂t
= 0. We furthermore assume that the binding of VEGF to ECs is slow
relative to the supply of VEGF from the tumor and the degradation, allowing us to
ignore the disturbance of the VEGF-field by the ECs. We can then approximate the
VEGF-field with a steady-state, analytical solution of Eq. (3), instead of solving it nu-
merically. Assuming a constant concentration cV (0) at the tumor boundary and open
boundary conditions at the parent vessel, the one-dimensional analytical solution of
the gradient at steady state becomes
cV (x2) = cV (0)e−x2/λ with λ =
√
D
V
. (4)
If the tumor is spherical and much larger relative to the simulation domain, we can
assume the tumor boundary is flat and approximate the VEGF gradient by a planar
gradient according to the analytical solution in Eq. (4) (Fig. 1B).
Chemotaxis up the VEGF-gradients is incorporated by including an extra reduc-
tion in energy for extensions into the ECM toward higher concentrations of VEGF
(as described in Merks et al. 2008). After we calculate the change in effective energy,
H , associated with a potential copying step according to Eq. (1), we subtract a
contribution due to chemotaxis. The energy change due to chemotaxis then becomes
Hchemotaxis = −χδ(σx,0)
(
cV (x) − cV
(x′)) (5)
where (x, x′) is a pair of adjacent lattice sites, with x′ the source site of the copy.
cV (x) is the local concentration of VEGF at site x, and χ is the strength of the
chemotactic response. Note that it is not possible to include the chemotaxis term
in the Hamiltonian (Eq. (1)), because it involves gradient calculations over the direc-
tion of copying. Since primarily the extending filopodia are able to sense and react
to chemotactic cues, we consider only extensions of cells into the ECM to contribute
chemotactically to the total energy (Merks et al. 2008). Including chemotactic retrac-
tion gives similar branching sprouts (results not shown). Figure 3B illustrates how in
our model the ECs move toward the tumor in response to the VEGF gradient.
2.3 ECM Proteolysis
We model the ECM using a PDE describing the evolution of a scalar field cE(x).
MMPs degrade the ECM at a rate proportional to the ECM concentrations:
∂cE(x, t)
∂t
= −δ(σx,0)EMcM(x, t)cE(x, t) (6)
where cE(x, t) and cM(x, t) represent the concentrations of ECM and MMPs, and
EM is a degradation constant. VEGF induces MMP-secretion by activating Notch
signaling (Plaisier et al. 2004; Funahashi et al. 2011); we therefore assume that ECs
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secrete MMPs at a rate proportional to the local VEGF concentration,
∂cM(x, t)
∂t
= αMVcV (x, t)
(
1 − δ(σx,0)
)
H
(
cM,max − cM(x, t)
)
− δ(σx,0)McM(x, t) + DM∇2cM(x, t), (7)
where cV (x, t) represents the concentration of VEGF, and αMV, M , and DM are the
secretion rate, decay rate, and diffusion coefficient of MMPs. The Kronecker-delta
expressions state that cells only secrete MMPs at the lattice sites they cover, while
the ECM is only degraded outside the cells. The heaviside step function, H(cM,max −
cM(x, t)), suppresses secretion of MMPs if the local MMP concentration exceeds
the maximum concentration of cM,max = 1. Note that in our model the nondiffusible
ECM components do not decay at lattice sites that are occupied by the cells of a
growing sprout. This is a simplified way to represent the balanced ECM decay and
production that preserves matrix integrity near the cell.
2.4 Numerics, Initial Conditions and Boundary Conditions of PDE
We solve Eqs. (6) and (7) numerically with a forward Euler method with fixed time
step on a square lattice with the same dimensions as the one used for the CPM. We
discretize the Laplacian in Eq. (7) using a five-point stencil method. To solve the
interaction of the PDE and CPM, we apply a first-order operator splitting strategy:
we run 15 iterations of the fixed time-step forward-Euler scheme between subsequent
MCSs with t = 1. We use zero boundary conditions for Eq. (7). We initialize the
simulations with a high uniform concentration ECM (cE,init(x) = 0.9) outside the
parent vessel, an intermediate concentration (cE(x) = 0.5) inside the vessel and a
semicircular gradient in front of the opening in the basal membrane (Fig. 1C), which
presents a biologically plausible starting situation.
2.5 Cellular Responses to ECM Components
To model haptokinesis, we assume that the membrane protrusion rate of ECs is fa-
vored at intermediate concentrations. A reverse Gaussian describes this dependence
of cell protrusion rate on ECM concentration, yielding the following haptokinesis
term:
H haptokinesis = −ηδ(σx,0)
(
−1 + 1
ρ
√
2π
e
− (cE(x′)−μ)2
2ρ2
)
, (8)
where η is the haptokinesis strength, μ = 0.5 is the intermediate ECM density with
ECM densities in our model with cE ∈ [0,1]; the standard deviation ρ is set to a
value ρ = 0.2 to ensure diversity of cell motility over the range of available ECM
values. The reverse Gaussian increases cell motility at intermediate ECM densities,
while reducing cell motility at high or low ECM densities (see Fig. 2B).
Figures 3C and D illustrate the effect of haptokinesis and ECM proteolysis on the
ECs. In Fig. 3C, we include the haptokinesis term (Eq. (8)) in the Hamiltonian, ini-
tiating the simulation with a uniform, high concentration of ECM components. This
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Table 2 Parameter settings for the simulations shown in Fig. 3
Parameter Value Description
A B C D E F
χ 0 6000 6000 6000 6000 6000 chemotaxis strength
η 0 0 200 200 200 200 haptokinesis strength
cE,init 0 0 0.9 0.9 0.9 0.9 initial ECM density
EM 0 0 0 2 × 10−3 2 × 10−3 2 × 10−3 decay rate ECM
ρmin 1 1 1 1 0.73 0.73 threshold ratio for proliferation
Γ 0 0 0 0 0 1000 haptotaxis strength
Other parameters: see Table 1
reduces the cellular motility and inhibits sprout formation. In Fig. 3D, the ECs also
produce proteolytic enzymes (Eq. (7)), which degrade ECM components (Eq. (6)).
The ECs can now break down the matrix and migrate away from the mother vessel,
producing “tracks” of intermediate ECM concentration on top of which cells have
highest motility.
2.6 Cell Proliferation
Following the suggestion that cell division occurs at gaps between ECs, due to the
release of contact inhibition (Ausprunk and Folkman 1977; Nelson and Chen 2003),
in our model cells divide with a probability dependent on the proportion of their
perimeter not bound to adjacent cells,
Pproliferation(i) =
{
0 if ρi < ρmin,
ρi − ρmin if ρi ≥ ρmin, (9)
where ρi is the ratio between cell-ECM perimeter and the total perimeter of a cell
with index σ = i,
ρi =
∑
(x,x′) δ(0, σx′)δ(σx, i)∑
(x,x′)(1 − δ(σx, σx′))δ(σx, i)
, (10)
with
∑
(x,x′) summing over all pairs of adjacent sites in the lattice and ρmin, a thresh-
old ratio. The numerator counts the number of sites of cell i adjacent to the ECM;
δ(0, σx′) selects adjacent site pairs at cell-ECM boundaries, and δ(σx, i) selects site
pairs of which x is in cell i. The denominator measures the perimeter of cell i, with
(1 − δ(σx, σx′)) selecting all cell interfaces.
The proliferation step (calculation of the probability and division of cells) is car-
ried out once every 5 MCS. For simplicity, we assume ECs divide perpendicular to
their long axis (Minc et al. 2011). Because in our model cells tend to stretch par-
allel to the vessel, in the direction of the VEGF gradient, this assumption agrees
phenomenologically with the experimental observation that endothelial cells divide
perpendicular to the long axis of the structure in which they reside, which VEGF
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potentially regulates (Zeng et al. 2007). To divide a CPM cell, we estimate the di-
rection of the cells’ minor axis from the cellular inertia tensor (Zajac et al. 2003;
Merks et al. 2006),
I (σ ) =
( ∑
x∈C(σ)(x2 − C2(σ ))2 −
∑
x∈C(σ)(x1 − C1(σ ))(x2 − C2(σ ))
−∑x∈C(σ)(x1 − C1(σ ))(x2 − C2(σ ))
∑
x∈C(σ)(x1 − C1(σ ))2
)
,
(11)
with C(i) = {x ∈ Z2 : σx = i}, the set of lattice sites covered by the cell with index
σ = i, and C(i) = 1|C(i)|
∑
x∈C(i) x, i.e., the center of mass of the cell with index σ =
i. The division plane, d , then becomes the minor axis of the cell: d = (I1,2, λb −I1,1),
with λb the larger eigenvalue of I (Zajac et al. 2003). To divide, we assign a new index
σ ′ to the sites at one side of the shortest axis of the dividing cell. We then assign
half the target area and target length of the parent cell to both daughter cells. We
assume that the ECs grow gradually after cell division. Cell growth is implemented
by increasing the target area AT by 2 lattice sites and the target length LT by 0.6
sites per 5 MCS. During angiogenesis, typically only stalk cells divide, but not the tip
cells or the quiescent endothelial cells in the main vessel (De Smet et al. 2009). To
represent quiescent ECs in the main vessel, we only allow for proliferation outside
the parent vessel, at a minimum distance of one cell length from the vessel wall. We
do not distinguish between tip cells and stalk cells in the present model, so all cells
outside the parent vessel can proliferate.
Figure 3E illustrates the effect of including EC proliferation in our model. It allows
the daughter vessel to grow toward the tumor without splitting up. This behavior of
our model partly agrees with experimental observation: Sprouting can occur without
proliferation, but proliferation is required for sustaining sprouting for a longer period
and to grow a large enough sprout that can reach the tumor (Ausprunk and Folkman
1977; Gerhardt 2008).
2.7 Haptotaxis
In vitro experiments have shown that gradients of ECM components can guide EC
migration (Senger et al. 2002). To mimic such ECM-guided cell migration, or hap-
totaxis, an additional energy term increases the probability of pseudopod extensions
toward higher ECM concentrations,
H haptotaxis = −Γ δ(σx,0)
(
cE(x)
1 + scE(x) −
cE(x′)
1 + scE(x′)
)
(12)
with cE(x), the local ECM density, Γ , the strength of the haptotactic response, and
s, a saturation parameter. The saturation term reduces haptotaxis at high ECM con-
centrations. Figure 3F and the Supplementary Movie 1 illustrate the effect of hapto-
taxis: It increases the radial dispersion of ECs and increases the formation of vessel
branches. The ECs are pulled toward freshly degraded parts of the ECM, which re-
duces the relative importance of the VEGF gradients.
In summary, the additional energy terms due to chemotaxis, haptotaxis and hap-
tokines are added to the change in effective energy associated with a potential copying
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step according to Eq. (1):
H = Hafter − Hbefore + Hchemotaxis + Hhaptotaxis + Hhaptokinesis (13)
where Hafter is the value of the Hamiltonian after the potential copying step and
Hbefore the original value.
3 Sensitivity Analysis
In order to find out which of the mechanisms of our model play a key role in sprouting
angiogenesis and to study the sensitivity of the model to parameter variations, we ran
simulations where we varied the parameter of interest and kept all other parameters
fixed. We use the parameters for the simulation in Fig. 3F as a reference parameter
set (see Table 1). For each parameter set, we simulated ten random realizations; Sup-
plementary Fig. 1 illustrates the variation found in these simulations for the reference
parameter set.
3.1 Morphometric Measures
We define the compactness, or C = Aobject/Aconvex hull, of the sprout as a measure of
branching (Merks et al. 2008), with Aobject the area of the largest set of connected
cells that is located outside the parent vessel, and Aconvex hull the area of the con-
vex hull of this set of cells. Thus, the compactness yields a value in the range [0,1]
with 1, a convex object (usually a sprout growing straight toward the tumor), and a
value approaching 0 indicating a connected, branched object. A disadvantage of this
measure is that extensive branching can result in high compactness as well, with the
branches filling up the space. We therefore also define the height of the sprout: It is
the distance between the bottom of the dish and the tip of the cell closest to the tumor,
disregarding cells dislodged from the main vessel. The size of the sprout is defined as
the number of cells in the largest connected component, including those cells located
in the parent vessel.
3.2 Chemotaxis and Haptokinesis
We first investigated the sensitivity to the chemotaxis parameter χ and the haptoki-
nesis parameter η (Fig. 4). The chemotactic strength does not strongly affect the
compactness (Fig. 4B) or the size of the sprout (Fig. 4D). Because chemotaxis pulls
the growing sprout in the direction of the tumor, the height of the sprouts increases
faster with higher values of the chemotaxis parameter (Fig. 4F).
The haptokinesis parameter, η, affects the compactness, height and size (Figs. 4C,
E, G). For zero haptokinesis, the sprouts grow slowly and do not branch, as indicated
by compactnesses close to 1 (see Fig. 4A). For relatively small values of haptokinesis,
the sprouts grow toward the tumor at a higher velocity, with no or few branches (Sup-
plementary Movie 2). For higher values of haptokinesis strength, the sprout velocity
decreases again because more branches are formed.
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Fig. 4 A Morphological response to chemotaxis parameter, χ (rows) and haptokinesis parameter, η
(columns). (B, D, F) Compactness (B), size (D), and height (F) of the growing sprout with varying chemo-
taxis strength χ (see legend in panel B). (C, E, G) Compactness (C), size (E), and height (G) of the
growing sprout with varying haptokinesis strength η (see legend in panel C). Error bars indicate standard
deviation, n = 10. Simulation results shown at 30000 MCS. All parameters except χ and η as in reference
parameter set (Table 1)
3.3 Haptotaxis
The haptotaxis parameter, Γ , strongly affects the degree of branching of the vascu-
lar trees (see Figs. 5A–D). The compactness (Fig. 5F) and sprout height (Fig. 5G)
poorly express this higher degree of branching, because the branches spread out over
the available space. A slight increase of compactness is observed toward to the end
of the simulation, because the continued growth (and lack of space) leads cells to fill
up the space between the branches. The size of the vascular tree (i.e., the number of
cells) increases with haptotaxis strength (Fig. 5H and Supplementary Movie 3), cor-
responding with the larger number of sprouts. Figure 5E shows what is the effect of
haptotaxis on branching: As the ECM gradient around the tip drives cells in opposite
directions, it causes the sprout to be pulled apart.
3.4 ECM Degradation and ECM Density
Next, we investigated how the rate of ECM degradation by MMPs affects angiogenic
sprouting. As Fig. 6 shows, faster ECM degradation produces less compact, higher
and bigger vascular sprouts, with a higher degree of branching. Slow ECM degrada-
tion produces much smaller, compact sprouts, which grow slowly toward the tumor.
Variations in secretion rate of MMPs will have similar effects (results not shown).
Figure 7 shows the effects of ECM density on the vascular tree. At low initial ECM
concentrations up to to 0.3 (Fig. 7A), the sprout does not grow; ECM concentrations
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Fig. 5 A–D Examples of growing sprouts after 30000 MCS with increasing haptotaxis strength Γ .
A Γ = 0. B Γ = 300. C Γ = 900. D Γ = 1500. E Close up of sprout tip at the onset of sprout split-
ting. ECM gradients around the sprout tip drives cells in the tip of the sprout in opposite directions. F–H
Compactness (F), height (G), and size (H) of the growing sprout with varying haptotaxis strength Γ . Error
bars indicate standard deviation, n = 8
Fig. 6 A–E Examples of growing sprouts after 30000 MCS with increasing MMP-dependent ECM degra-
dation rate, EM. A EM = 1 × 10−3; B EM = 2 × 10−3; C EM = 3 × 10−3; D EM = 4 × 10−3;
E EM = 5 × 10−3. F–H Compactness (F), size (G), and height (H) of the growing sprout with varying
MMP-dependent ECM degradation rate. Error bars indicate standard deviation, n = 7
are below the minimum concentration for haptokinetic cell motility, and proteolysis
decreases the ECM density even more. At intermediate ECM densities of around
0.5, the ECM concentration produces optimal haptokinesis, and the cells in the tip
of the sprout migrate so fast that the sprout loses its coherence and branches split
off (Fig. 7C). Higher ECM densities of around 0.7 (Fig. 7C) again slow down the
ECs, creating a rapidly growing stable sprout. The nominal value of 0.9 used for the
ECM density in our simulations (Fig. 7D) slows down cells producing shorter, more
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Fig. 7 A–E Examples of growing sprouts after 30000 MCS with increasing, intial ECM concentration,
cE,init. A cE,init = 0.3; B cE,init = 0.5; C cE,init = 0.7; D cE,init = 0.9. E Close up of a growing sprout
in ECM field with cE,init = 0.9. Intermediate ECM concentrations (as marked with the concentration
isoline) appear at the lateral sides of the tip of the sprout, showing how haptokinesis can induce sprout
splitting. F–H Compactness (F), size (G), and height (H) of the growing sprout with varying initial ECM
concentrations. Haptotaxis strength Γ = 1000, other parameters as in Table 1. Error bars indicate standard
deviation, n = 10
widely branched vessels. These effects are mostly due to haptokinesis (see Fig. 2B
and Eq. (8)). This can be explained by the fact that intermediate ECM concentrations
are mainly found at the lateral sides of the tip of the sprout, which causes cells to
grow in opposite directions (Fig. 7E).
4 Discussion
In this paper, we presented a cell-based model to explore the potential role of ECM-
guided cell motility in angiogenesis. The model describes cell–matrix interactions on
the level of individual cells. Although in this model cells can form a coherent “sprout”
by chemotacting toward an external source of VEGF (Fig. 3B), only with haptokine-
sis, proliferation, and proteolysis do the cells in our model organize into a branched
vessel tree (Fig. 3E). Branching is enhanced by including haptotaxis (Figs. 3E and 5).
In haptokinesis and haptotaxis, the local concentration of ECM and the local gradi-
ents guide the velocity and movement direction of ECs. The ECs regulate the local
ECM concentrations by secreting matrix-degrading MMPs, and in this way regulate
their own motility and that of subsequent ECs.
We thus explored the ECs’ possible use of the ECM as a “guidance cue,” in a
way similar to that proposed by Yin and coworkers (Yin et al. 2008). According to
their observations in microfluidics set-ups and in absence of a preexisting ECM, Yin
et al. proposed that ECs secrete collagen and change their velocity in response to
local collagen concentrations. The ECs were also thought to become less sensitive
to collagen concentration in response to VEGF. This would reduce the ECs’ ability
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to retrace paths of collagen at higher VEGF concentrations. Using an agent-based
model, it was proposed that these rules allow ECs to form coherent tracks of cells
navigating toward a VEGF-producing tumor, in a mechanism closely resembling one
proposed previously for the formation of pheromone-mediated army ant raid patterns
(Deneubourg et al. 1989).
Although the cell behaviors represented in the model of Yin et al. (2008) were
based on experimental observations, they may only apply to in vitro situations in ab-
sence of external ECM materials. In vivo and in many in vitro systems (e.g., Folkman
and Hauenschild 1980; Koolwijk et al. 1996) endothelial cells are embedded in an ex-
tracellular matrix, and ECs’ main effect on the ECM may be matrix degradation, not
secretion. We therefore focused our study on ECM degradation. In addition, by using
a multiparticle cell-based method, like the cellular Potts model, we could describe
cell behavior in more detail than what is possible using continuum models (Levine
et al. 2001a; Levine et al. 2001b) or agent-based formalisms that describe endothe-
lial cells as point particles (Anderson and Chaplain 1998; Plank and Sleeman 2003;
Yin et al. 2008; McDougall et al. 2006b). This allowed us to include stretch induced
cell division in our model. Also, in our model the flexible shapes of the cells at the
tips were required for branch splitting.
The work presented in this paper is primarily intended as an explorative study:
what cellular self-organization potentially results from ECM-guided cell migration,
and what role could it play in angiogenesis? Thus, the model necessarily is a strong
simplification of angiogenesis in vitro or in vivo. Nevertheless, the following aspects
of the model behavior agree with experimental observation. Without ECM degra-
dation, the cells cannot invade the matrix. This model behavior agrees with studies
that demonstrate that MMPs are essential for cell migration through 3D ECM matri-
ces (Ghajar et al. 2006; van Hinsbergh and Koolwijk 2008). Furthermore, we have
shown that sprout formation depends on the concentrations of matrix proteins, with
vessels growing fastest at intermediate ECM densities. At low densities no sprouts
will form and at very high densities the vasculature will grow at a lower rate. This
phenomenon has also been observed in experimental studies (Ghajar et al. 2006;
Ingber and Folkman 1989). Although it is questionable that the secretion of MMPs by
all cells and the subsequent degradation around the sprout is a realistic assumption of
our model, a study of extracellular proteolytic activity during angiogenesis has found
that capillary sprouts are surrounded by “empty space,” resulting from fibrin degra-
dation (Pepper 2001). In our model, such “empty space” along the stalk of the sprout
is required for the formation of stable sprouts: Haptotaxis and haptokinesis lock the
cells into a central zone where the ECM concentration is higher than in the immediate
vicinity of sprouts, so cells cannot leave the sprout. A further realistic aspect of our
model is the requirement for cell proliferation: in the first phase of angiogenesis the
growth of the sprout is mainly caused by migrating cells, in a later stage proliferation
is responsible for sprout growth. Without proliferation, we can reproduce branching
sprouts, but they remain small in size and ECs may detach from the main sprout
(Fig. 3D). Experiments show that both EC migration as well as proliferation plays a
role in the formation of vessel sprouts. If proliferation is inhibited sprouts can form,
but will not reach the tumor (Paweletz and Knierim 1989).
However, the model also produces unrealistic phenomenology. The growing
sprouts in our simulations form bulbs at the end of branches. Cells at the tip of a
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sprout divide at a higher rate, because they tend to have more contact with the sur-
rounding ECM. We could improve on this aspect of our model by reducing cell di-
vision in the very tip of the sprout, which is in agreement with the observation that
mainly stalk cells located just behind the tip of the sprout proliferate. Although the
model oversimplifies many aspects of angiogenesis, it illustrates some basic prin-
ciples of how cell-ECM interactions can coordinate collective cell behavior during
branching growth. A next step will be to differentiate between tip, stalk, and phalanx
cells: Tip cells are more motile than stalk cells; they lead the sprout, navigate by ex-
tending filopodia, and invade the ECM by releasing proteases. Stalk cells follow the
tip cells, and form fewer filopodia than tip cells; they proliferate and secrete ECM
components. In our current model, all cells are sensitive to chemotactic and haptotac-
tic cues; they can all proliferate and secrete MMPs and ECM components. In reality,
those “tasks” are divided between tip cells and stalk cells. In addition, since prolif-
eration is induced by VEGF (Gerhardt et al. 2003), we could improve the model not
only by restricting proliferation to stalk cells, but also by increasing the probability
of cell division with higher VEGF concentrations.
The ECM is now modeled as a homogenous field with initially a uniform con-
centration of ECM components. In reality, the matrix is highly heterogeneous with
irregular concentrations of a variety of matrix components. In our model, we do not
distinguish between alternative ECM proteins, like collagen, fibrin, and fibronectin.
In fact, the composition of the ECM affects the ability of ECs to form networks (Dye
et al. 2004) and sprouts (Kaijzel et al. 2006) in vitro. Also, the current model cap-
tures the local concentrations of ECM components, but not the fiber orientations of
the ECM components as in previous studies (Bauer et al. 2007, 2009; McDougall
et al. 2006a; Dallon and Sherratt 1998). Future models will include more detailed
descriptions of the ECM, and cell-ECM interactions that may change local fiber ori-
entation and resulting cell guidance: shear stress, matrix rigidity, and the direction of
matrix fibers, can all guide cells when migrating into the matrix (Li et al. 2005).
A further simplification of our model is the representation of the secretion and
function of MMPs. We assumed that the secretion of MMPs does not relate to the
ECM density in the vicinity of the EC. In reality, cells can fine-tune proteolysis to
prevent excessive break down of the matrix. We could therefore model mechanisms
that inhibit or limit proteolysis or limits proteolysis when ECM densities are low
enough for invasion. Also, it was long thought that the only function of MMPs was
to degrade ECM components. Recent studies, however, show that extracellular prote-
olysis can also regulate endothelial cell function in a more indirect way. Growth fac-
tors bound to ECM components can be released by MMPs (Hawinkels et al. 2008).
Furthermore, several angiogenic growth factors require proteolytic processing to be-
come active (van Hinsbergh and Koolwijk 2008). Proteolytic fragments of the ECM
and other molecules have been reported to show regulatory activity in angiogene-
sis, either positive or negative. They are often called matrikines (van Hinsbergh and
Koolwijk 2008). In our model, we could add matrix bound factors to the ECM, such
as certain VEGF isoforms, which can be released or activated by MMPs. These fac-
tors will set up steep local gradients and this will certainly affect cell migration, as in
related models of network formation (Köhn-Luque et al. 2011).
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5 Ancilliary Materials
Supplementary Movie 1 Example of simulation with reference parameter settings
(Table 1).
Supplementary Movie 2 Example of simulation with high chemotaxis strength
(χ = 7500) and low haptokinesis strength (η = 150). The other parameters are as
given in Table 1.
Supplementary Movie 3 Example of simulation with high haptotaxis strength (Γ =
1800), other parameters are given in Table 1.
Supplementary Figure 1 Ten random examples of growing sprouts after 30000
MCS with parameters as listed in Table 1.
Supplementary Text 1 Example of simulation with realistic parameter values and
dimensions.
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